Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
NAS[10681545]
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
44(13/31/0)
|
IEA
|
IL1B |
interleukin 1 beta |
2q14 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|
CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
OXTR |
oxytocin receptor |
3p25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
TH |
tyrosine hydroxylase |
11p15.5 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
ISS
|
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(0/4/0)
|
IEA
|
KAT2B |
K(lysine) acetyltransferase 2B |
3p24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IEA
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
IEA
|